The number of CD8 T cells making granzymes A and B was significantly higher in the combination treatment group compared to the other treatment groups (Figs. 4e, f, Supplementary Fig. 6D), suggesting that the combination treatment enhanced the effector function of CD8 T cells infiltrating the tumor. The gene discussed is GZMA; the disease is neoplasm.